MILLER MICHAEL PATRICK

SEC Form 4 insider trading activity

MILLER MICHAEL PATRICK has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including PBYI, RIGL, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Nov 14, 2026.

On the most recent filing, MILLER MICHAEL PATRICK is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, MILLER MICHAEL PATRICK reported no open-market purchases and 1 open-market sale totaling $121K in PBYI.

Companies traded

Other insiders at PBYI

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$121K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
PBYISale$121KNov 14SEC ↗
Showing 1–1 of 1
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Nov 11, 2025PBYISale$97K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has MILLER MICHAEL PATRICK made?

MILLER MICHAEL PATRICK has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including PBYI, RIGL since 2025.

Which companies does MILLER MICHAEL PATRICK trade?

MILLER MICHAEL PATRICK has filed SEC Form 4 disclosures for 2 companies, including PBYI, RIGL.

When was MILLER MICHAEL PATRICK's most recent SEC Form 4 filing?

MILLER MICHAEL PATRICK's most recent SEC Form 4 filing on Tracefour is dated Nov 14, 2026.

What is MILLER MICHAEL PATRICK's total buy and sell value in the current window?

Inside the rolling retention window, MILLER MICHAEL PATRICK bought $0 and sold $121K based on SEC Form 4 filings.

What was MILLER MICHAEL PATRICK's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 15,000 PBYI shares on 2026-11-11, worth $121K, per SEC Form 4 filings.